Globus Medical Inc (GMED)
51.25
+0.90
(+1.79%)
USD |
NYSE |
Apr 22, 16:00
51.26
0.00 (0.00%)
Pre-Market: 20:00
Globus Medical Revenue (Quarterly): 616.53M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 616.53M |
| September 30, 2023 | 383.64M |
| June 30, 2023 | 291.62M |
| March 31, 2023 | 276.69M |
| December 31, 2022 | 274.50M |
| September 30, 2022 | 254.15M |
| June 30, 2022 | 263.65M |
| March 31, 2022 | 230.55M |
| December 31, 2021 | 250.02M |
| September 30, 2021 | 229.72M |
| June 30, 2021 | 251.02M |
| March 31, 2021 | 227.34M |
| December 31, 2020 | 233.44M |
| September 30, 2020 | 216.10M |
| June 30, 2020 | 148.92M |
| March 31, 2020 | 190.58M |
| December 31, 2019 | 211.67M |
| September 30, 2019 | 196.22M |
| June 30, 2019 | 194.54M |
| March 31, 2019 | 182.95M |
| December 31, 2018 | 195.94M |
| September 30, 2018 | 169.24M |
| June 30, 2018 | 173.38M |
| March 31, 2018 | 174.41M |
| December 31, 2017 | 176.03M |
| Date | Value |
|---|---|
| September 30, 2017 | 151.74M |
| June 30, 2017 | 152.39M |
| March 31, 2017 | 155.81M |
| December 31, 2016 | 151.59M |
| September 30, 2016 | 135.65M |
| June 30, 2016 | 137.49M |
| March 31, 2016 | 139.26M |
| December 31, 2015 | 142.59M |
| September 30, 2015 | 136.99M |
| June 30, 2015 | 133.57M |
| March 31, 2015 | 131.60M |
| December 31, 2014 | 128.80M |
| September 30, 2014 | 117.79M |
| June 30, 2014 | 113.57M |
| March 31, 2014 | 114.21M |
| December 31, 2013 | 115.24M |
| September 30, 2013 | 107.19M |
| June 30, 2013 | 107.01M |
| March 31, 2013 | 105.02M |
| December 31, 2012 | 100.54M |
| September 30, 2012 | 94.76M |
| June 30, 2012 | 95.98M |
| March 31, 2012 | 94.72M |
| December 31, 2011 | 87.99M |
| September 30, 2011 | 84.27M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
148.92M
Minimum
Jun 2020
616.53M
Maximum
Dec 2023
260.05M
Average
233.44M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.815B |
| Intuitive Surgical Inc | 1.891B |
| Glaukos Corp | 82.36M |
| PROCEPT BioRobotics Corp | 43.58M |
| Paragon 28 Inc | 60.56M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.03M |
| Total Expenses (Quarterly) | 590.58M |
| EPS Diluted (Quarterly) | 0.11 |
| Enterprise Value | 6.837B |
| Gross Profit Margin (Quarterly) | 56.94% |
| Profit Margin (Quarterly) | 2.44% |
| Earnings Yield | 2.28% |
| Operating Earnings Yield | 3.45% |
| Normalized Earnings Yield | 3.038 |